Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2005 1
2006 5
2007 5
2008 5
2009 3
2010 8
2011 7
2012 6
2013 8
2014 6
2015 8
2016 3
2017 4
2018 4
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 26847832

76 results
Results by year
Filters applied: . Clear all
Page 1
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M. Yanagimoto H, et al. Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
[Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma].
Kopchak VM, Kopchak KV, Romaniv IaV. Kopchak VM, et al. Klin Khir. 2006 Feb;(2):23-5. Klin Khir. 2006. PMID: 16826811 Clinical Trial. Russian.
[A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy].
Ichikawa Y, Yamada D, Eguchi H, Iwagami Y, Noda T, Asaoka T, Wada H, Kawamoto K, Gotoh K, Kobayashi S, Tatsumi M, Takeyari M, Mori M, Doki Y. Ichikawa Y, et al. Gan To Kagaku Ryoho. 2017 Nov;44(12):2014-2016. Gan To Kagaku Ryoho. 2017. PMID: 29394852 Japanese.
Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Suenaga S, et al. Anticancer Res. 2014 Jan;34(1):141-6. Anticancer Res. 2014. PMID: 24403454
Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
Yamagishi Y, Higuchi H, Izumiya M, Sakai G, Iizuka H, Nakamura S, Adachi M, Hozawa S, Takaishi H, Hibi T. Yamagishi Y, et al. J Gastroenterol. 2010 Nov;45(11):1146-54. doi: 10.1007/s00535-010-0258-9. Epub 2010 Jun 15. J Gastroenterol. 2010. PMID: 20549255
Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Nakai Y, Isayama H, Kawabe T, Tsujino T, Yoshida H, Sasaki T, Tada M, Arizumi T, Yagioka H, Kogure H, Togawa O, Ito Y, Matsubara S, Hirano K, Sasahira N, Omata M. Nakai Y, et al. Pancreas. 2008 Nov;37(4):405-10. doi: 10.1097/MPA.0b013e3181706d93. Pancreas. 2008. PMID: 18953253
Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
Tokunaga M, Baron B, Kitagawa T, Tokuda K, Kuramitsu Y. Tokunaga M, et al. Anticancer Res. 2015 Nov;35(11):6063-7. Anticancer Res. 2015. PMID: 26504030
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Dalgleish AG, Stebbing J, Adamson DJ, Arif SS, Bidoli P, Chang D, Cheeseman S, Diaz-Beveridge R, Fernandez-Martos C, Glynne-Jones R, Granetto C, Massuti B, McAdam K, McDermott R, Martín AJ, Papamichael D, Pazo-Cid R, Vieitez JM, Zaniboni A, Carroll KJ, Wagle S, Gaya A, Mudan SS. Dalgleish AG, et al. Br J Cancer. 2016 Sep 27;115(7):789-96. doi: 10.1038/bjc.2016.271. Epub 2016 Sep 6. Br J Cancer. 2016. PMID: 27599039 Free PMC article. Clinical Trial.
Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer.
Kurihara T, Kogo M, Ishii M, Shimada K, Yoneyama K, Kitamura K, Shimizu S, Yoshida H, Kiuchi Y. Kurihara T, et al. Cancer Chemother Pharmacol. 2015 Dec;76(6):1217-24. doi: 10.1007/s00280-015-2887-4. Epub 2015 Nov 11. Cancer Chemother Pharmacol. 2015. PMID: 26560484
Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats.
Akladios C, Ignat M, Mutter D, Aprahamian M. Akladios C, et al. J Cancer Res Clin Oncol. 2017 Jan;143(1):29-34. doi: 10.1007/s00432-016-2265-6. Epub 2016 Sep 12. J Cancer Res Clin Oncol. 2017. PMID: 27620742
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page